These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24994594)

  • 21. c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.
    Song JJ; Kim JH; Sun BK; Alcala MA; Bartlett DL; Lee YJ
    Cell Signal; 2010 Mar; 22(3):377-85. PubMed ID: 19861161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
    Congleton J; Shen M; MacDonald R; Malavasi F; Yen A
    Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
    Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K
    Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The E3 Ubiquitin Ligase c-Cbl Inhibits Microglia-Mediated CNS Inflammation by Regulating PI3K/Akt/NF-κB Pathway.
    Dong L; Li YZ; An HT; Wang YL; Chen SH; Qian YJ; Wang K; Zhen JL; Fan Z; Gong XL; Zheng Y; Wang XM
    CNS Neurosci Ther; 2016 Aug; 22(8):661-9. PubMed ID: 27156691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation.
    Li X; Wei W; Huynh H; Zuo H; Wang X; Wan Y
    Elife; 2015 Jul; 4():e07217. PubMed ID: 26173181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 PI-3K subunit.
    Cerboni C; Gismondi A; Palmieri G; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 1998 Mar; 28(3):1005-15. PubMed ID: 9541596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.
    Fang D; Wang HY; Fang N; Altman Y; Elly C; Liu YC
    J Biol Chem; 2001 Feb; 276(7):4872-8. PubMed ID: 11087752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of ubiquitin ligase Cbl induced by twist haploinsufficiency in Saethre-Chotzen syndrome results in increased PI3K/Akt signaling and osteoblast proliferation.
    Guenou H; Kaabeche K; Dufour C; Miraoui H; Marie PJ
    Am J Pathol; 2006 Oct; 169(4):1303-11. PubMed ID: 17003487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Src kinase activity is essential for osteoclast function.
    Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
    J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K/Akt signaling and osteoblast survival.
    Dufour C; Guenou H; Kaabeche K; Bouvard D; Sanjay A; Marie PJ
    Bone; 2008 Jun; 42(6):1032-9. PubMed ID: 18374639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency.
    Strait K; Li Y; Dillehay DL; Weitzmann MN
    Int J Mol Med; 2008 Apr; 21(4):521-5. PubMed ID: 18360699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway.
    Bunda S; Qin K; Kommaraju K; Heir P; Ohh M
    Oncogene; 2015 Feb; 34(6):789-97. PubMed ID: 24469048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl.
    Sanjay A; Miyazaki T; Itzstein C; Purev E; Horne WC; Baron R
    FEBS J; 2006 Dec; 273(23):5442-56. PubMed ID: 17094785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cbl-family proteins as regulators of cytoskeleton-dependent phenomena.
    Lee H; Tsygankov AY
    J Cell Physiol; 2013 Dec; 228(12):2285-93. PubMed ID: 23744514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries.
    Tang Z; Wang Y; Fan Y; Zhu Y; Chien S; Wang N
    Circulation; 2008 Aug; 118(7):764-72. PubMed ID: 18663086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis.
    Lane HC; Anand AR; Ganju RK
    Int Immunol; 2006 Aug; 18(8):1315-25. PubMed ID: 16798838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation.
    Arron JR; Vologodskaia M; Wong BR; Naramura M; Kim N; Gu H; Choi Y
    J Biol Chem; 2001 Aug; 276(32):30011-7. PubMed ID: 11406619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl.
    Hartley D; Meisner H; Corvera S
    J Biol Chem; 1995 Aug; 270(31):18260-3. PubMed ID: 7629144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation.
    Song C; Tan P; Zhang Z; Wu W; Dong Y; Zhao L; Liu H; Guan H; Li F
    FASEB J; 2018 Jun; 32(6):3215-3228. PubMed ID: 29401617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.